Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference44 articles.
1. IDF Diabetes Atlas | Tenth Edition. (n.d.). Retrieved from https://diabetesatlas.org/
2. Hossain, U., Das, A. K., Ghosh, S., & Sil, P. C. (2020). An overview on the role of bioactive α-glucosidase inhibitors in ameliorating diabetic complications. Food and Chemical Toxicology, 145, 111738. https://doi.org/10.1016/J.FCT.2020.111738
3. Riyaphan, J., Pham, D. C., Leong, M. K., & Weng, C. F. (2021). In silico approaches to identify polyphenol compounds as α-glucosidase and α-amylase inhibitors against type-II diabetes. Biomolecules, 11(12), 1877. https://doi.org/10.3390/BIOM11121877
4. Akmal, M., & Wadhwa, R. (2022). Alpha glucosidase inhibitors. NCBI Bookshelf. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK557848/
5. Smith, D. L., Orlandella, R. M., Allison, D. B., & Norian, L. A. (2021). Diabetes medications as potential calorie restriction mimetics—A focus on the alpha-glucosidase inhibitor acarbose. GeroScience, 43(3), 1123–1133. https://doi.org/10.1007/S11357-020-00278-X/FIGURES/1